UCB has entered into a strategic partnership with Chinese biotech firm Antengene to develop...
Merck
President Donald Trump has announced new agreements with leading pharmaceutical manufacturers designed to lower...
The Trump administration has announced agreements with nine additional pharmaceutical companies aimed at aligning...
Merck has announced that its investigational oral PCSK9 inhibitor, enlicitide decanoate, has successfully met...
WASHINGTON, D.C. – In a significant move, Robert F. Kennedy Jr.’s revamped vaccine advisory...
